The article explores the relationship between patents and human rights in accessing medicines. It delves into the challenges faced in providing essential medicines, the role of patents in pharmaceutical markets, and the international human rights framework. The researchers analyze the impact of patent protection on access to medicines, discussing the right to health, life, and benefits of science. They also examine the TRIPS Agreement and its implications for pharmaceutical patents. The study aims to understand if a one-size-fits-all approach is suitable in balancing patent rights and human rights in accessing medicines.